drugset / Trial / NCT01002820
A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601
NaSingle-groupOpen-labelTreatment
Summary
This study is designed to provide ganaxolone to those patients deriving significant benefit from current treatment in protocol 1042-0601.
Timeline
- Start
- 2009-10
- Primary completion
- 2010-10
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ganaxolone | Small molecule | 500 mg | — |
| Subject | Ganaxolone | Small molecule | 1500 mg | — |